Miracll Chemicals Co.,Ltd (SHE:300848)
China · Delayed Price · Currency is CNY 18.08
+0.48 (2.73%)
Apr 29, 2026, 3:06 PM CST
Miracll Chemicals Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,929 | 1,744 | 1,653 | 1,471 | 1,473 | 1,285 |
Other Revenue | 2.42 | 2.42 | 5.38 | 4.39 | 2.44 | 12.98 |
| 1,932 | 1,747 | 1,658 | 1,475 | 1,475 | 1,298 | |
Revenue Growth (YoY) | 16.34% | 5.31% | 12.43% | 0.01% | 13.66% | 71.47% |
Cost of Revenue | 1,701 | 1,528 | 1,451 | 1,274 | 1,276 | 1,097 |
Gross Profit | 230.63 | 218.14 | 207.71 | 201.03 | 198.57 | 200.56 |
Selling, General & Admin | 74.97 | 70.93 | 62.16 | 53.79 | 44.18 | 38.36 |
Research & Development | 80.89 | 76.41 | 91 | 72.82 | 70.33 | 56.39 |
Other Operating Expenses | -3.08 | 1.09 | -2.23 | 1.39 | 7.2 | 3.68 |
Operating Expenses | 153.52 | 149.17 | 151.47 | 131.86 | 121.8 | 99.78 |
Operating Income | 77.11 | 68.97 | 56.24 | 69.17 | 76.77 | 100.78 |
Interest Expense | -24.97 | -24.97 | -9.01 | -6.93 | -5.52 | -3.94 |
Interest & Investment Income | 14.72 | 10.88 | 19.15 | 21.67 | 24.11 | 23.98 |
Currency Exchange Gain (Loss) | -0.69 | -0.69 | 1.4 | 1.02 | 4.35 | -1.21 |
Other Non Operating Income (Expenses) | -14.98 | -0.92 | -0.88 | -1.44 | -1.19 | -0.87 |
EBT Excluding Unusual Items | 51.19 | 53.28 | 66.89 | 83.49 | 98.53 | 118.74 |
Gain (Loss) on Sale of Investments | 4.65 | 4.82 | -2.56 | -0.63 | -2.1 | 1.79 |
Gain (Loss) on Sale of Assets | -0.11 | -0.01 | - | - | - | - |
Asset Writedown | 9.62 | -0.19 | -0.2 | -0.11 | -0.39 | -0.29 |
Other Unusual Items | 10.71 | 10.71 | 7.88 | 7 | 15.24 | 10.66 |
Pretax Income | 76.05 | 68.6 | 72.01 | 89.76 | 111.29 | 130.9 |
Income Tax Expense | 0.01 | -0.18 | 1.47 | 1.65 | 0.46 | 11.57 |
Earnings From Continuing Operations | 76.04 | 68.78 | 70.53 | 88.1 | 110.83 | 119.32 |
Minority Interest in Earnings | 14.95 | 13.15 | 7.05 | -0.24 | 0.45 | -0.18 |
Net Income | 90.99 | 81.93 | 77.59 | 87.86 | 111.28 | 119.15 |
Net Income to Common | 90.99 | 81.93 | 77.59 | 87.86 | 111.28 | 119.15 |
Net Income Growth | 9.11% | 5.59% | -11.70% | -21.04% | -6.60% | 16.77% |
Shares Outstanding (Basic) | 431 | 431 | 408 | 399 | 391 | 387 |
Shares Outstanding (Diluted) | 431 | 431 | 408 | 399 | 391 | 387 |
Shares Change (YoY) | 2.91% | 5.59% | 2.25% | 2.14% | 0.98% | 16.77% |
EPS (Basic) | 0.21 | 0.19 | 0.19 | 0.22 | 0.28 | 0.31 |
EPS (Diluted) | 0.21 | 0.19 | 0.19 | 0.22 | 0.28 | 0.31 |
EPS Growth | 6.02% | - | -13.64% | -22.70% | -7.51% | - |
Free Cash Flow | -233.48 | -71.59 | -805.67 | -556.11 | -366.66 | -41.01 |
Free Cash Flow Per Share | -0.54 | -0.17 | -1.97 | -1.39 | -0.94 | -0.11 |
Dividend Per Share | 0.050 | 0.050 | 0.070 | 0.077 | 0.051 | 0.068 |
Dividend Growth | -28.57% | -28.57% | -8.97% | 49.90% | -25.00% | 100.00% |
Gross Margin | 11.94% | 12.49% | 12.52% | 13.63% | 13.46% | 15.45% |
Operating Margin | 3.99% | 3.95% | 3.39% | 4.69% | 5.21% | 7.77% |
Profit Margin | 4.71% | 4.69% | 4.68% | 5.96% | 7.54% | 9.18% |
Free Cash Flow Margin | -12.09% | -4.10% | -48.58% | -37.70% | -24.86% | -3.16% |
EBITDA | 159.72 | 143.02 | 96.04 | 97.51 | 102.58 | 123.26 |
EBITDA Margin | 8.27% | 8.19% | 5.79% | 6.61% | 6.95% | 9.50% |
D&A For EBITDA | 82.6 | 74.04 | 39.8 | 28.34 | 25.8 | 22.48 |
EBIT | 77.11 | 68.97 | 56.24 | 69.17 | 76.77 | 100.78 |
EBIT Margin | 3.99% | 3.95% | 3.39% | 4.69% | 5.21% | 7.77% |
Effective Tax Rate | 0.01% | - | 2.05% | 1.84% | 0.41% | 8.84% |
Revenue as Reported | 1,747 | 1,747 | 1,658 | 1,475 | 1,475 | 1,298 |
Advertising Expenses | - | 2.39 | 2.9 | 1.2 | 0.3 | 0.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.